Skip to main content
x

New Product Announcement Background
New Product Announcement Background

Announcing our
first FDA-approved
treatment

Our-Pipeline-Slide
slide-2

Passionate About
Helping Patients

Our Technology Slide
slide-4

EXPLORE OUR
INNOVATIVE TECHNOLOGIES

Neurelis-News-slide
slide-3

NEURELIS IS
MAKING HEADLINES

Partner-With-Us-Slide
slide-4

HELP US
Help Patients

OUR PASSION IS PROGRESS

Neurelis is an innovation-driven neuroscience company that provides a differentiated approach to target unmet medical needs. Our application of novel technologies is designed to enhance therapeutic benefit and patient care.

OUR PRODUCT

We have reached a milestone in patient care with the first FDA-approved treatment from Neurelis.

OUR PIPELINE

Our pipeline currently includes several investigational product candidates at various stages of development.

OUR TECHNOLOGIES

Neurelis has a proprietary technology portfolio that includes Intravail®, ProTek®, and Hydrogel® for drug delivery enhancement. These three non-invasive drug delivery and stabilization technologies are applicable to a wide range of molecules including therapeutic proteins, peptides, and non-peptide large and small molecules. Our technologies offer exceptional potential value in enhancing drug development and clinical performance.

ABOUT NEURELIS

Neurelis is a neuroscience-based specialty pharmaceutical company dedicated to enhancing therapeutic benefit and addressing unmet needs in patient care.

KEEP CURRENT

Get the most up-to-date information about Neurelis and our products.

HAVE A QUESTION ABOUT NEURELIS?

Please contact us if you have any questions about Neurelis or any of the products we are currently developing. 

Contact Us